Featured Research

from universities, journals, and other organizations

New Role For Immune System Player May Help Improve Cancer Vaccines

Date:
November 1, 2002
Source:
NIH/National Cancer Institute
Summary:
Researchers have discovered that a molecule best known for its anti-microbial properties also has the ability to activate key cells in the immune response. This newly discovered function, reported in the Nov. 1, 2002, issue of Science, suggests the molecule, a peptide called -defensin 2, may be useful in the development of more effective cancer vaccines.

Researchers have discovered that a molecule best known for its anti-microbial properties also has the ability to activate key cells in the immune response. This newly discovered function, reported in the Nov. 1, 2002, issue of Science, suggests the molecule, a peptide called -defensin 2, may be useful in the development of more effective cancer vaccines. Scientists have found that -defensin 2 initiates a chain of events leading to the growth and multiplication of T cells, components of the immune system that recognize and kill foreign cells that have invaded the body.

Defensins are known to be an important component of the body's immediate response to infection. -defensin 2 attacks and destroys a broad range of bacteria as part of the innate immune system, the body's first line of defense against such infections.

The new finding links -defensin 2 to the second arm of the immune system, adaptive immunity. The adaptive immune response combats pathogens that evade the body's initial defense mechanisms. Unlike innate immunity, the adaptive immune system develops specifically in response to an infection, changing as needed to ward off each invader.

"This link between the innate and adaptive immune systems is important for our understanding of the body's ability to detect infection," said Arya Biragyn, Ph.D., National Cancer Institute (NCI) staff scientist and first author of the study. "-defensin 2 is likely to play an important role in the immune system's ability to recognize protein fragments from the body's own cells, including tumor cells."

Working in both mice and laboratory cell cultures, Biragyn and his colleagues found that -defensin 2 directly activates immune cells known as dendritic cells. Once activated, dendritic cells interact with other components of the immune system to stimulate the multiplication of a subset of T cells that will recognize and destroy infected cells. Dendritic cells can also trigger attack of tumor cells by the immune system.

"When we administered -defensin 2 to mice, we observed a robust response among cells involved in anti-tumor immunity," noted NCI's Larry W. Kwak, M.D., Ph.D., the senior investigator on the study. Researchers hope to take advantage of this property by incorporating -defensin 2 into cancer vaccines.

Cancer vaccines are an investigational therapy designed to program the body's own immune system to attack a tumor. The vaccine does this by training T cells to recognize cancerous cells. Scientists hope that adding -defensin 2 to such vaccines will promote the growth and multiplication of the tumor-destroying cells, improving patient response to the therapy.

Similarly, researchers hope that -defensin 2 will also be useful in improving AIDS vaccines in the future.

For more information on cancer, please visit NCI's Web site at http://www.cancer.gov


Story Source:

The above story is based on materials provided by NIH/National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Cancer Institute. "New Role For Immune System Player May Help Improve Cancer Vaccines." ScienceDaily. ScienceDaily, 1 November 2002. <www.sciencedaily.com/releases/2002/11/021101070242.htm>.
NIH/National Cancer Institute. (2002, November 1). New Role For Immune System Player May Help Improve Cancer Vaccines. ScienceDaily. Retrieved August 31, 2014 from www.sciencedaily.com/releases/2002/11/021101070242.htm
NIH/National Cancer Institute. "New Role For Immune System Player May Help Improve Cancer Vaccines." ScienceDaily. www.sciencedaily.com/releases/2002/11/021101070242.htm (accessed August 31, 2014).

Share This




More Health & Medicine News

Sunday, August 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins